SV2007002555A - Penemes triciclicos de 6-alquilideno como inhibidores de b-lactamasas clase d - Google Patents

Penemes triciclicos de 6-alquilideno como inhibidores de b-lactamasas clase d

Info

Publication number
SV2007002555A
SV2007002555A SV2006002555A SV2006002555A SV2007002555A SV 2007002555 A SV2007002555 A SV 2007002555A SV 2006002555 A SV2006002555 A SV 2006002555A SV 2006002555 A SV2006002555 A SV 2006002555A SV 2007002555 A SV2007002555 A SV 2007002555A
Authority
SV
El Salvador
Prior art keywords
class
penemes
tricycle
inhibitors
beta
Prior art date
Application number
SV2006002555A
Other languages
English (en)
Spanish (es)
Inventor
Tarek Suhayl Mansour
Aranapakam Mudumbai Vankatesan
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of SV2007002555A publication Critical patent/SV2007002555A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SV2006002555A 2005-06-01 2006-05-31 Penemes triciclicos de 6-alquilideno como inhibidores de b-lactamasas clase d SV2007002555A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68622105P 2005-06-01 2005-06-01

Publications (1)

Publication Number Publication Date
SV2007002555A true SV2007002555A (es) 2007-02-02

Family

ID=37836305

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2006002555A SV2007002555A (es) 2005-06-01 2006-05-31 Penemes triciclicos de 6-alquilideno como inhibidores de b-lactamasas clase d

Country Status (14)

Country Link
US (1) US20060276446A1 (enExample)
EP (1) EP1885358A2 (enExample)
JP (1) JP2008542376A (enExample)
CN (1) CN101189010A (enExample)
AR (1) AR054467A1 (enExample)
AU (1) AU2006287938A1 (enExample)
BR (1) BRPI0611491A2 (enExample)
CA (1) CA2610478A1 (enExample)
GT (1) GT200600235A (enExample)
MX (1) MX2007015173A (enExample)
PE (1) PE20070010A1 (enExample)
SV (1) SV2007002555A (enExample)
TW (1) TW200716104A (enExample)
WO (1) WO2007030166A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR039774A1 (es) * 2002-05-01 2005-03-02 Wyeth Corp 6-alquiliden-penems biciclicos como inhibidores de beta-lactamasas
AR039475A1 (es) * 2002-05-01 2005-02-23 Wyeth Corp 6-alquiliden-penems triciclicos como inhibidores de beta-lactamasa
TW200716102A (en) * 2005-06-01 2007-05-01 Wyeth Corp Bicyclic 6-alkylidene-penems as class-D β -lactamases inhibitors
US8512789B2 (en) * 2005-11-23 2013-08-20 The Coca-Cola Company High-potency sweetener composition with dietary fiber and compositions sweetened therewith
US8945652B2 (en) 2005-11-23 2015-02-03 The Coca-Cola Company High-potency sweetener for weight management and compositions sweetened therewith
US8524304B2 (en) 2005-11-23 2013-09-03 The Coca-Cola Company High-potency sweetener composition with probiotics/prebiotics and compositions sweetened therewith
JP2012121809A (ja) * 2009-02-26 2012-06-28 Eisai R & D Management Co Ltd 多環式化合物の製造法およびその中間体
US20110288063A1 (en) * 2010-05-19 2011-11-24 Naeja Pharmaceutical Inc. Novel fused bridged bicyclic heteroaryl substituted 6-alkylidene penems as potent beta-lactamase inhibitors
CN104341345B (zh) * 2014-10-24 2016-03-23 海门海康生物医药科技有限公司 一种2-甲氧基-6-酮-5,6,7,8-四氢喹啉的合成方法
US12240855B2 (en) 2019-03-06 2025-03-04 Daiichi Sankyo Company, Limited Pyrrolopyrazole derivative

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ286898B6 (en) * 1994-04-25 2000-07-12 Smithkline Beecham Plc Pharmaceutical preparation
US20040132706A1 (en) * 2001-10-05 2004-07-08 Daniela Salvemini Composition comprising a catalyst for the dismutation of superoxide and use of the composition for preventing and treating hypotension
US20040132708A1 (en) * 2002-05-01 2004-07-08 Wyeth Process for preparing 6-alkylidene penem derivatives
AR039774A1 (es) * 2002-05-01 2005-03-02 Wyeth Corp 6-alquiliden-penems biciclicos como inhibidores de beta-lactamasas
AR039476A1 (es) * 2002-05-01 2005-02-23 Wyeth Corp Proceso para preparar derivados de 6-alquiliden penem
AR039475A1 (es) * 2002-05-01 2005-02-23 Wyeth Corp 6-alquiliden-penems triciclicos como inhibidores de beta-lactamasa
TW200716102A (en) * 2005-06-01 2007-05-01 Wyeth Corp Bicyclic 6-alkylidene-penems as class-D β -lactamases inhibitors

Also Published As

Publication number Publication date
MX2007015173A (es) 2008-02-15
CN101189010A (zh) 2008-05-28
JP2008542376A (ja) 2008-11-27
US20060276446A1 (en) 2006-12-07
WO2007030166A3 (en) 2007-05-24
CA2610478A1 (en) 2007-03-15
WO2007030166A2 (en) 2007-03-15
AU2006287938A1 (en) 2007-03-15
PE20070010A1 (es) 2007-01-12
BRPI0611491A2 (pt) 2010-12-21
EP1885358A2 (en) 2008-02-13
GT200600235A (es) 2007-03-29
AR054467A1 (es) 2007-06-27
TW200716104A (en) 2007-05-01

Similar Documents

Publication Publication Date Title
DOP2010000218A (es) Inhibidores de beta-lactamasa
CO2017013360A2 (es) Inhibidores de metalo-beta-lactamasa
CR10748A (es) Compuesto de indol
UY31171A1 (es) Anhídridos y polímeros de esteres borónicos cíclicos y acíclicos, sus enantiómeros, sus sales farmacéuticamente aceptables, composiciones conteniéndolos y aplicaciones.
CU20120071A7 (es) DERIVADOS DE N1-PIRAZOLOESPIROCETONA ÚTILES COMO INHIBIDORES DE ACETIL-CoA CARBOXILASA
DOP2014000212A (es) Compuestos inhibidores de beta-lactamasas
MX2014014653A (es) Nuevo inhibidor de beta-lactamasa y proceso para prepararlo.
NO20090313L (no) Derivater og analoger av N-etylkinoloner og N-etylazakinoloner
CR10277A (es) Pirazolquinolonas como potentes inhibidores de parp
PE20120057A1 (es) Compuestos de tiazolopiridina moduladores de sirtuina
CR11031A (es) Composiciones de enzima digestiva estable
CO6511220A2 (es) Quinazolinas como inhibidores de los canales iónicos de potasio
MX2009006171A (es) Metodo para la prevencion o el tratamiento de isquemia de miocardio.
CR11629A (es) INHIBIDORES HETEROCICLICOS DE ESTEAROIL-CoA- DESATURASA.
CU20100035A7 (es) Derivados de ciclopropilamida como moduladores h3
EA201490450A1 (ru) Новые ингибиторы ферментов
BR112022008938A2 (pt) Derivados de 1-aminossulfonil-2-carboxipirrol como inibidores de metalo-beta-lactamase
CR7508A (es) 6-alquiliden-penems biciclicos como inhibidores de b-lactamasas
GT200600235A (es) Penemes triciclicos de 6-alquilideno como inhibidores de beta-lactamasas clase d
GT200600236A (es) PENEMES BICICLICOS DE 6-ALQUILIDENO COMO INHIBIDORES DE beta-LACTAMASAS CALSE D
UY32258A (es) Derivados de la espirociclobutilpiperidina
UY32197A (es) Sinergismo antibiotico
BR112023003452A2 (pt) Síntese de derivados ácidos do pirrol
CR9553A (es) Penemes biciclicos de 6-alquilideno como inhibidores de b-lactamasas clase d
EA202191461A1 (ru) Комбинированные композиции, содержащие ингибитор -лактамазы, и пути их применения